Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $4,823 - $6,314
594 Added 1.72%
35,201 $367,000
Q3 2023

Nov 08, 2023

SELL
$7.48 - $10.7 $533,309 - $762,888
-71,298 Reduced 67.32%
34,607 $352,000
Q2 2023

Aug 04, 2023

BUY
$7.2 - $9.47 $294,688 - $387,597
40,929 Added 62.99%
105,905 $797,000
Q1 2023

May 09, 2023

BUY
$8.36 - $11.37 $360,784 - $490,683
43,156 Added 197.78%
64,976 $575,000
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $36,808 - $43,892
-4,630 Reduced 17.5%
21,820 $198,000
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $34,197 - $59,570
-4,985 Reduced 15.86%
26,450 $215,000
Q2 2022

Aug 08, 2022

SELL
$7.38 - $10.4 $123,496 - $174,033
-16,734 Reduced 34.74%
31,435 $241,000
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $514,214 - $658,727
-70,152 Reduced 59.29%
48,169 $452,000
Q4 2021

Feb 15, 2022

BUY
$7.9 - $10.19 $614,951 - $793,209
77,842 Added 192.3%
118,321 $948,000
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $201,430 - $244,696
-24,037 Reduced 37.26%
40,479 $396,000
Q2 2021

Aug 06, 2021

BUY
$9.9 - $11.56 $29,759 - $34,749
3,006 Added 4.89%
64,516 $638,000
Q1 2021

May 13, 2021

SELL
$10.34 - $12.81 $2.67 Million - $3.3 Million
-257,800 Reduced 80.74%
61,510 $708,000
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $1.04 Million - $1.34 Million
121,221 Added 61.2%
319,310 $3.08 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $170,371 - $252,277
-19,880 Reduced 9.12%
198,089 $1.78 Million
Q2 2020

Aug 12, 2020

BUY
$8.12 - $13.12 $172,817 - $279,232
21,283 Added 10.82%
217,969 $2.69 Million
Q1 2020

May 13, 2020

SELL
$6.69 - $13.45 $3.05 Million - $6.13 Million
-456,117 Reduced 69.87%
196,686 $1.77 Million
Q4 2019

Feb 13, 2020

BUY
$6.53 - $10.72 $4.26 Million - $7 Million
652,803 New
652,803 $6.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.